KIAA1147 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.88140000023651E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
2.91033863675239E-12 |
Normal-vs-Stage2 |
6.096100E-02 |
Normal-vs-Stage3 |
3.662400E-01 |
Normal-vs-Stage4 |
2.825800E-01 |
Stage1-vs-Stage2 |
4.846500E-02 |
Stage1-vs-Stage3 |
1.70570000013193E-07 |
Stage1-vs-Stage4 |
1.20960019778238E-10 |
Stage2-vs-Stage3 |
2.040600E-01 |
Stage2-vs-Stage4 |
2.064100E-02 |
Stage3-vs-Stage4 |
1.106160E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
3.08459999986965E-07 |
Normal-vs-AfricanAmerican |
5.538500E-02 |
Normal-vs-Asian |
7.697000E-01 |
Caucasian-vs-AfricanAmerican |
7.072400E-01 |
Caucasian-vs-Asian |
4.896000E-01 |
AfricanAmerican-vs-Asian |
5.995000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
2.22909999999521E-05 |
Normal-vs-Female |
2.31609999999938E-05 |
Male-vs-Female |
4.187000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.747850E-01 |
Normal-vs-Age(41-60Yrs) |
3.60210000049932E-07 |
Normal-vs-Age(61-80Yrs) |
5.839000E-04 |
Normal-vs-Age(81-100Yrs) |
7.760200E-01 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.316600E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.354800E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.532600E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.824400E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.131230E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.008400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
1.201850E-03 |
Normal-vs-Grade 2 |
1.04259934019524E-11 |
Normal-vs-Grade 3 |
5.116100E-03 |
Normal-vs-Grade 4 |
1.132010E-02 |
Grade 1-vs-Grade 2 |
1.062160E-01 |
Grade 1-vs-Grade 3 |
2.840000E-03 |
Grade 1-vs-Grade 4 |
4.08100000459655E-08 |
Grade 2-vs-Grade 3 |
4.386400E-04 |
Grade 2-vs-Grade 4 |
2.40429898212824E-12 |
Grade 3-vs-Grade 4 |
1.89266999999216E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
<1E-12 |
Normal-vs-ccB subtype |
8.954200E-01 |
ccA subtype-vs-ccB subtype |
2.66453525910038E-15 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.168750E-04 |
Normal-vs-N1 |
2.824300E-04 |
N0-vs-N1 |
8.87560000051302E-07 |
|
|